Summer means new Interns! Since everyones heart may be racing a bit, heres a non #COVID19 thread about some tachycardias w/three take away points!

#FOAMed #TipsForNewDocs #MedTweetorial @ALiEMteam @cameronks @EMSwami @AliRaja_MD @srrezaie @RuralMedStudent @laxswamy @medburnbook
“Patient Stability” is a general & broad term that some argue has a lot of grey area. Generally, it refers to hemodynamics (ie. SpO2, HR and BP) responsible for important organ perfusion

#FOAMed #CardioTwitter @HippoEM @TravisABenson @feleciadsouza @wandering_er @reverendofdoubt
Always clinically assess patients for instability. Go through the ABCs before the H+P. Look at their mental status, vitals, etc as this will guide your treatment of their arrhythmia

@HippoEducation @CORD_EM @EMFundamentals @FoundationsEM @EMBoardBombs @purdy_eve @iem_student
1st Take away point when treating tachycardia (& every patient (in #EmergencyMedicine)) = Determine if clinically stable or unstable!

#cardiotwitter #FOAMed @alifarzadmd @smithECGBlog @EMS12Lead @amalmattu @ECGQuizzes @ECGfan @HedayatiMD @ECGTeacher @paramedickiwi @Thind888
Before going any further, let’s first understand some important terms and definitions that will be part of our discussion
Another critical clinical distinction that needs to be made is differentiating V-Tach from SVT w/Aberrancy. One can use Brugada’s criteria to help better identify VT

#FOAMed @HumanFact0rz @DogICUma @EBMgoneWILD @claski @KristinJBoyle @Rothy001 @SorenRudolph @AndrewTabner
REBEL EM has a great post about differentiating VT from SVT w/Aberrancy found here:

https://rebelem.com/svt-aberrancy-versus-vt/">https://rebelem.com/svt-aberr... via @srrezaie & @EMSwami

So 2nd take away point: Use Brugada’s Criteria to help differentiate VT from SVT w/Aberrancy!
When talking about treatment, antiarrhythmics can be confusing and complicated. Thankfully @RxKeySlides created this awesome infographic to visually help simplify each drug’s effect on the cardiac action potential!

#FOAMed @GhanaboyPharmd @HeavnerPharmD @pharmso_hard @iEMPharmD
A frequently debated topic is the treatment of stable wide complex tachycardia. Although a small study, the PROCAMIO trial showed procainamide has less major cardiac adverse events than amiodarone:
https://rebelem.com/rebelcast-procamio/">https://rebelem.com/rebelcast... via @srrezaie
Lets finish this off with a patient case. This 70s male presented with light-headedness, generalized weakness & SBP in the mid 90s. (Known by cardiology to have slightly low BP)

#FOAMed #cardiotwitter @EM_RESUS @FYang_EP @jigneshpatelMD @amalmattu @dreamboat1317 @Maimonides_EM
Following failed AICD overdrive pacing, 100 mg of Procainamide was given over 2 minutes four times before being placed on a procainamide gtt. He reported feeling better after the boluses and here’s his EKG:

#FOAMed #CardioTwitter @EricLeeMD @DuncanGrossman @AllNYCEM @FalconERDoc
This leads us to the 3rd & final teaching point: Consider Procainamide for stable patients in wide complex tachycardia.

Heres the #summary of the three teaching points and thanks for reading!

#FOAMed #cardiotwitter #MedTwitter #MedTweetorial
You can follow @MRamzyDO.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: